Literature DB >> 23566162

A novel three-dimensional stromal-based model for in vitro chemotherapy sensitivity testing of leukemia cells.

Omar S Aljitawi1, Dandan Li, Yinghua Xiao, Da Zhang, Karthik Ramachandran, Lisa Stehno-Bittel, Peter Van Veldhuizen, Tara L Lin, Suman Kambhampati, Rama Garimella.   

Abstract

The disparate response of leukemia cells to chemotherapy in vivo, compared to in vitro, is partly related to the interaction of leukemic cells and the three-dimensional bone marrow stromal microenvironment. We investigated the effects of chemotherapy agents on leukemic cell lines co-cultured with human bone marrow mesenchymal stem cells (hu-BM-MSCs) in a three-dimensional model (3D). Comparison was made to leukemic cells treated in suspension, or grown on a hu-BM-MSC monolayer (2D conditions). We demonstrated that leukemic cells cultured in 3D were more resistant to drug-induced apoptosis compared to cells cultured in 2D or in suspension. We also demonstrated significant differences in leukemic cell response to chemotherapy using different leukemic cell lines cultured in 3D. We suggest that the differential responses to chemotherapy in 3D may be related to the expression of N-cadherin in the co-culture system. This unique model provides an opportunity to study leukemic cell responses to chemotherapy in 3D.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23566162      PMCID: PMC4090917          DOI: 10.3109/10428194.2013.793323

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  31 in total

1.  A phase 1 dose-escalation study of ARRY-520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias.

Authors:  Hanna Jean Khoury; Guillermo Garcia-Manero; Gautam Borthakur; Tapan Kadia; Maria Cielo Foudray; Martha Arellano; Amelia Langston; Beverly Bethelmie-Bryan; Selena Rush; Kevin Litwiler; Sharon Karan; Heidi Simmons; Adam I Marcus; Mieke Ptaszynski; Hagop Kantarjian
Journal:  Cancer       Date:  2011-12-02       Impact factor: 6.860

2.  Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38-/CD123+ leukemic stem cells by chemotherapy-resistance.

Authors:  Lei Zhi; Min Wang; Qing Rao; Fan Yu; Yingchang Mi; Jianxiang Wang
Journal:  Cancer Lett       Date:  2010-05-04       Impact factor: 8.679

3.  Factors in human serum affecting the proliferation of normal and leukemic cells.

Authors:  P J Burke; C H Diggs; A H Owens
Journal:  Cancer Res       Date:  1973-04       Impact factor: 12.701

4.  Taking cell-matrix adhesions to the third dimension.

Authors:  E Cukierman; R Pankov; D R Stevens; K M Yamada
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

5.  Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation.

Authors:  H Asou; S Tashiro; K Hamamoto; A Otsuji; K Kita; N Kamada
Journal:  Blood       Date:  1991-05-01       Impact factor: 22.113

Review 6.  Tumor microenvironment and drug resistance in hematologic malignancies.

Authors:  Zhi-Wei Li; William S Dalton
Journal:  Blood Rev       Date:  2006-08-22       Impact factor: 8.250

7.  Activity of anticancer agents in a three-dimensional cell culture model.

Authors:  Victor Sanjit Nirmalanandhan; Alicia Duren; Peter Hendricks; George Vielhauer; Gurusingham Sitta Sittampalam
Journal:  Assay Drug Dev Technol       Date:  2010-07-27       Impact factor: 1.738

8.  Engineering tumors with 3D scaffolds.

Authors:  Claudia Fischbach; Ruth Chen; Takuya Matsumoto; Tobias Schmelzle; Joan S Brugge; Peter J Polverini; David J Mooney
Journal:  Nat Methods       Date:  2007-09-02       Impact factor: 28.547

Review 9.  The use of 3-D cultures for high-throughput screening: the multicellular spheroid model.

Authors:  Leoni A Kunz-Schughart; James P Freyer; Ferdinand Hofstaedter; Reinhard Ebner
Journal:  J Biomol Screen       Date:  2004-06

10.  Influence of humoral regulators on proliferation and maturation of normal and leukemic cells.

Authors:  J E Karp; P J Burke
Journal:  Cancer Res       Date:  1976-05       Impact factor: 12.701

View more
  30 in total

Review 1.  A hostel for the hostile: the bone marrow niche in hematologic neoplasms.

Authors:  Daniela S Krause; David T Scadden
Journal:  Haematologica       Date:  2015-11       Impact factor: 9.941

Review 2.  Three dimensional de novo micro bone marrow and its versatile application in drug screening and regenerative medicine.

Authors:  Guanqun Li; Xujun Liu; Qian Du; Mei Gao; Jing An
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

Review 3.  Modeling human bladder cancer.

Authors:  Cassandra Ringuette-Goulet; Stéphane Bolduc; Frédéric Pouliot
Journal:  World J Urol       Date:  2018-06-14       Impact factor: 4.226

Review 4.  Screening out irrelevant cell-based models of disease.

Authors:  Peter Horvath; Nathalie Aulner; Marc Bickle; Anthony M Davies; Elaine Del Nery; Daniel Ebner; Maria C Montoya; Päivi Östling; Vilja Pietiäinen; Leo S Price; Spencer L Shorte; Gerardo Turcatti; Carina von Schantz; Neil O Carragher
Journal:  Nat Rev Drug Discov       Date:  2016-09-12       Impact factor: 84.694

5.  A Novel 3-Dimensional Co-culture Method Reveals a Partial Mesenchymal to Epithelial Transition in Breast Cancer Cells Induced by Adipocytes.

Authors:  Nikitha K Pallegar; Chantae J Garland; Mathepan Mahendralingam; Alicia M Viloria-Petit; Sherri L Christian
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-11-24       Impact factor: 2.673

6.  Ellipsoid Segmentation Model for Analyzing Light-Attenuated 3D Confocal Image Stacks of Fluorescent Multi-Cellular Spheroids.

Authors:  Michaël Barbier; Steffen Jaensch; Frans Cornelissen; Suzana Vidic; Kjersti Gjerde; Ronald de Hoogt; Ralph Graeser; Emmanuel Gustin; Yolanda T Chong
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

Review 7.  Tissue engineered models of healthy and malignant human bone marrow.

Authors:  Alan Chramiec; Gordana Vunjak-Novakovic
Journal:  Adv Drug Deliv Rev       Date:  2019-04-17       Impact factor: 15.470

Review 8.  Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics.

Authors:  Andrew Goodspeed; Laura M Heiser; Joe W Gray; James C Costello
Journal:  Mol Cancer Res       Date:  2015-08-06       Impact factor: 5.852

9.  Alginate foam-based three-dimensional culture to investigate drug sensitivity in primary leukaemia cells.

Authors:  Mahroo Karimpoor; Eva Yebra-Fernandez; Maryam Parhizkar; Mine Orlu; Duncan Craig; Jamshid S Khorashad; Mohan Edirisinghe
Journal:  J R Soc Interface       Date:  2018-04       Impact factor: 4.118

10.  JAK-STAT inhibitor as a potential therapeutic opportunity in AML patients resistant to cytarabine and epigenetic therapy.

Authors:  Govind Babu; Padmaparna Chaudhuri; Manoj Rajappa; Manjusha Biswas; Bipinesh Sansar; Chethan Rajegowda; Aneesha Radhakrishnan; Jayshree Advani; Biplab Tewary; Padhma Radhakrishnan; Saravanan Thiyagarajan; Aditi Chatterjee; Ram Shankar Upadhayaya; Pradip K Majumder
Journal:  Cancer Biol Ther       Date:  2020-12-27       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.